David Friedman
Board Member
Benitec Biopharma Inc. (BNTC)Equibles does not estimate personal net worth.
About David Friedman
David Friedman is recorded as Board Member at Benitec Biopharma Inc. (BNTC) since May 22, 2026. David Friedman was last confirmed as CEO at Levi Strauss & Co (LEVI) in a filing dated February 27, 2020. Benitec Biopharma Inc. reported in an 8-K filed May 29, 2026 that David Friedman was appointed director, effective May 22, 2026. Benitec Biopharma Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Benitec Biopharma Inc. includes Dr. Jerel Banks (CEO and Chairman), Megan Boston (CFO), Sophie Mukadam (COO) and 7 others.
“On May 22, 2026, the Board of Directors (the "Board") of Benitec Biopharma Inc. (the "Company") appointed David Friedman to serve as a director of the Board, effective as of such date.”
Affiliation history
-
Current
2026-05-22–present
-
Start not stated–2020-02-27
Last confirmed by a filing; no departure on record
Company network
Leadership on record at Benitec Biopharma Inc.
- Dr. Jerel Banks CEO, Chairman
- Megan Boston CFO
- Sophie Mukadam COO
- Dr. Sharon Mates Board Member
- Edward Smith Board Member
- J. Kevin Buchi Board Member
- Kishan "Kishen" Mehta Board Member
- Kishan ("Kishen") Mehta Board Member
- Kishen Mehta Board Member
- Peter Francis Board Member